Atea Pharmaceuticals annual net debt
2021
2022
2023
2024
2025
Atea Pharmaceuticals Net Debt Growth & History (AVIR)
Atea Pharmaceuticals's net debt was −$94.9M for fiscal 2025.
View full Atea Pharmaceuticals company overviewAtea Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$94.9M | −$31.8M | — |
| 2024 | 2024-12-31 | −$63.1M | $78.4M | — |
| 2023 | 2023-12-31 | −$141.4M | $43.9M | — |
| 2022 | 2022-12-31 | −$185.3M | $578.8M | — |
| 2021 | 2021-12-31 | −$764.2M | — | — |
Atea Pharmaceuticals quarterly net debt
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$76.1M | $10.4M | — |
| Q1 2026 | 2026-03-31 | −$78.7M | $39.3M | — |
| Q4 2025 | 2025-12-31 | −$94.9M | −$31.8M | — |
| Q3 2025 | 2025-09-30 | −$76.3M | $20.3M | — |
| Q2 2025 | 2025-06-30 | −$86.5M | $154.9M | — |
| Q1 2025 | 2025-03-31 | −$117.9M | $40.7M | — |
| Q4 2024 | 2024-12-31 | −$63.1M | $78.4M | — |
| Q3 2024 | 2024-09-30 | −$96.6M | $38.7M | — |
| Q2 2024 | 2024-06-30 | −$241.4M | −$30.4M | — |
| Q1 2024 | 2024-03-31 | −$158.7M | $21.6M | — |
| Q4 2023 | 2023-12-31 | −$141.4M | $43.9M | — |
| Q3 2023 | 2023-09-30 | −$135.3M | $37.8M | — |
| Q2 2023 | 2023-06-30 | −$210.9M | $470.1M | — |
| Q1 2023 | 2023-03-31 | −$180.3M | $522.4M | — |
| Q4 2022 | 2022-12-31 | −$185.3M | $578.8M | — |
| Q3 2022 | 2022-09-30 | −$173.1M | $666.3M | — |
| Q2 2022 | 2022-06-30 | −$681.0M | $135.1M | — |
| Q1 2022 | 2022-03-31 | −$702.7M | $130.6M | — |
| Q4 2021 | 2021-12-31 | −$764.2M | — | — |
| Q3 2021 | 2021-09-30 | −$839.4M | — | — |
| Q2 2021 | 2021-06-30 | −$816.1M | — | — |
| Q1 2021 | 2021-03-31 | −$833.3M | — | — |
Atea Pharmaceuticals net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Atea Pharmaceuticals's net debt increased from −$764.2M to −$94.9M, a change of $669.3M. The latest reported quarter, Q2 2026, shows −$76.1M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Atea Pharmaceuticals source filings ↗